ADA example [Bioanalytics]

posted by mittyri – Russia, 2019-03-18 22:20 (995 d 18:57 ago) – Posting: # 20047
Views: 3,958

Hi Helmut,

Thank you so much for the detailed answer!

» » Even in analytical methodology (say QC samples): isn't possible to handle that values (as they are) for example for the mean evaluation for some level of QC sample?

» Not sure what you mean here.

Sorry for incomplete/incorrect question.
Say ADA, getting cut-off point (IV B FDA)
What would be a best tactics for cut-off point selection?
Say the data of healthy volunteers is {100, BLOQ, BLOQ}


Edit: Guidance linked. [Helmut]

Kind regards,
Mittyri

Complete thread:

Activity
 Admin contact
21,788 posts in 4,557 threads, 1,548 registered users;
online 21 (0 registered, 21 guests [including 3 identified bots]).
Forum time: Wednesday 17:17 CET (Europe/Vienna)

There is no adequate defense, except stupidity,
against the impact of a new idea.    Percy Williams Bridgman

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5